Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of maternal hypothermia after scheduled cesarean delivery under spinal anesthesia with active warming of intravenous fluids: an exploratory double-blind randomized controlled trial (CESAR-RESOL2).

International journal of obstetric anesthesia·2026
Same author

Absence of oral intake during labour: frequency and determinants in a national population-based study.

British journal of anaesthesia·2026
Same author

Cryoanalgesia for pain management after open thoracotomy: a reply.

Anaesthesia·2026
Same author

Pain management in childbirth: neuraxial analgesia and drug alternatives.

Anaesthesia, critical care & pain medicine·2026
Same author

Pain management after elective caesarean section under neuraxial anaesthesia: an updated systematic review and procedure-specific postoperative pain management (PROSPECT) recommendations.

Anaesthesia·2026
Same author

Guidelines 2024: Emergency intubation of an adult outside the operating room and intensive care unit.

Anaesthesia, critical care & pain medicine·2026

Related Experiment Video

Updated: May 23, 2026

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine
09:37

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine

Published on: August 24, 2018

Prohemostatic interventions in obstetric hemorrhage.

Marie-Pierre Bonnet1, Olga Basso

  • 1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. marie-pierre.bonnet@mail.mcgill.ca

Seminars in Thrombosis and Hemostasis
|April 19, 2012
PubMed
Summary

Severe obstetric hemorrhage can cause maternal death. While hypercoagulable, pregnant patients can develop coagulopathy. Caution is advised for high fresh frozen plasma to red blood cell ratios and procoagulant agents in obstetric hemorrhage management due to limited evidence.

More Related Videos

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

Related Experiment Videos

Last Updated: May 23, 2026

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine
09:37

Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine

Published on: August 24, 2018

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Critical Care Medicine

Background:

  • Obstetric hemorrhage is a leading cause of maternal morbidity and mortality worldwide.
  • Pregnancy induces a hypercoagulable state, but severe hemorrhage can precipitate acquired coagulopathy.
  • Management often borrows from trauma protocols, despite distinct physiological differences.

Purpose of the Study:

  • To review current prohemostatic treatments for obstetric hemorrhage.
  • To evaluate the applicability of trauma-based transfusion strategies (e.g., high FFP:RBC ratios) in obstetric settings.
  • To assess the role and evidence base for procoagulant agents in managing obstetric bleeding.

Main Methods:

  • Literature review and synthesis of existing evidence on obstetric hemorrhage management.
  • Comparison of hemostatic changes in obstetric versus trauma patients.
  • Analysis of current guidelines and expert opinions on transfusion protocols and procoagulant use.

Main Results:

  • High fresh frozen plasma to red blood cell (FFP:RBC) ratios, while used in trauma, require cautious adoption in obstetric hemorrhage due to lack of specific evidence.
  • Multidisciplinary transfusion protocols tailored for massive obstetric hemorrhage are the current best practice.
  • Procoagulant agents show promise but need further validation in obstetric hemorrhage contexts.

Conclusions:

  • Clinicians should exercise caution regarding the wholesale adoption of trauma-derived transfusion ratios in obstetric hemorrhage.
  • Evidence-based, multidisciplinary transfusion protocols remain the cornerstone of managing massive obstetric bleeding.
  • Further research is essential to establish the efficacy and safety of procoagulant agents in obstetric hemorrhage.